Leland Watkins
Family Medicine · Glendale, CANPI 1528094430
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $538 and has fallen 55.6% since, to $239 in 2025.
Across 99 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$309
- Gilead$273
- Lilly USA, LLC$240
- Pfizer$144
- GSK$122
- Sanofi Pasteur Inc.$120
- plus $856 from 21 others
What the payments were for
- Food & beverage$2,064100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $309 |
| Gilead | 12 | $273 |
| Lilly USA, LLC | 12 | $240 |
| Pfizer | 11 | $144 |
| GSK | 6 | $122 |
| Sanofi Pasteur Inc. | 6 | $120 |
| Amarin Pharma, Inc. | 5 | $118 |
| Teva Pharmaceuticals USA, Inc. | 4 | $94 |
| Sanofi-aventis U.S. LLC | 3 | $66 |
| Organogenesis Inc. | 1 | $50 |
| Philips North America LLC | 2 | $49 |
| Amgen | 2 | $49 |
| Exact Sciences | 2 | $48 |
| Merck | 3 | $44 |
| Abbott | 2 | $43 |
| Ironwood Pharmaceuticals, Inc | 2 | $38 |
| Dexcom, Inc. | 1 | $34 |
| Krystal Biotech Inc | 1 | $33 |
| Biohaven Pharmaceuticals, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $23 |
| Novartis | 1 | $21 |
| Viatris Specialty LLC | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Mannkind Corporation | 1 | $15 |
How this compares
$2,064 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 66 | $46,504 |
| TradjentaLinagliptin | 15 | $11,744 |
| Potassium Chloride | 22 | $2,105 |
| Atorvastatin Calcium | 108 | $1,194 |
| Tamsulosin Hcl | 53 | $1,037 |
| Metoprolol Succinate | 54 | $984 |
| SynthroidLevothyroxine Sodium | 16 | $983 |
| Rosuvastatin Calcium | 43 | $940 |
| Losartan Potassium | 82 | $595 |
| Levothyroxine Sodium | 64 | $573 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 11 | $562 |
| Amlodipine Besylate | 133 | $487 |
| Telmisartan | 27 | $486 |
| Pantoprazole Sodium | 24 | $409 |
| Pravastatin Sodium | 38 | $362 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $144 | $46,50466 claims |
| Boehringer IngelheimTradjenta | $25 | $11,74415 claims |
| AbbVieSynthroid | $309 | $98316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,533 family medicine providers in California.
Other family medicine in Glendale
- Narineh ArutyounianGlendale$76K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.